Celanese reported net margins of 20.0% in its most recent quarter, roughly flat compared to the year-ago period. This margin resilience indicates the company has been able to pass along higher input costs to customers without losing significant volume. Celanese's diversified product portfolio, spanning engineered materials, acetyl chain, and ethylene vinyl acetate, provides multiple avenues to leverage its pricing power. The company operates 30 global production facilities strategically located near key customers and suppliers, further enhancing its ability to manage costs and maintain margins. Celanese's disciplined capital allocation, including targeted growth investments and consistent share repurchases, has strengthened its balance sheet and improved returns on invested capital (ROIC). The company's ROIC has averaged 15.8% over the last four quarters. Given Celanese's demonstrated pricing power, diversified business, and prudent financial management, I believe the company is well-positioned to navigate the current inflationary environment and continue delivering solid financial performance. The stock's valuation of 13.4x forward P/E, a discount to its historical average, makes the shares attractive for long-term investors seeking exposure to a high-quality specialty chemicals franchise.

Research these companies